Do you have COVID-19? SAB-185 is being assessed in a research study supported by the National Institutes of Health.

Learn More Here


Management Team

Eddie J. Sullivan, PhD
Co-Founder, President & CEO

Christoph Bausch, PhD
Chief Science Officer

Russell Beyer, CMA
Chief Financial Officer

Kipp Erickson, PhD
Chief Operating Officer

Rick Finnegan
Chief Business Officer

Tom Luke, MD
Chief Medical Officer

Jerry Pommer, MSc, PAS, DACAWS
Chief Compliance Officer

Melissa Ullerich 
Chief Corporate Communications
Investor Relations Officer

Board of Directors

Samuel J. Reich
Executive Chairman

David Link
Vice Chairman
Former Executive Vice President
Sanford Health

Eddie J. Sullivan, PhD
Co-Founder, President, CEO
SAB Biotherapeutics

Christine Hamilton
Co-Founder, SAB Biotherapeutics
Managing Partner, Christiansen Land & Cattle
Co-Owner BioDak, LLC

Bill Polvino, MD
Bridge Medicines

Mervyn Turner, PhD
Former Head of Strategy

Jeffrey G. Spragens

Eddie Hamilton, DVM MAgr
Co-Founder, Board Observer

Scientific Advisory Board

Jim Robl, PhD
Retired Biotechnology Executive & Professor

Scott A. Lesley, Ph.D.
Vice President, Discovery Biologics
Merck Research Laboratories

Arturo Casadevall, MD, PhD
Bloomberg Distinguished Professor of Molecular Microbiology & Immunology and Infectious Diseases
Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine

Michael Haller, MD, MS–CI
Chief, Program Director, Pediatric Endocrinology and Professor
University of Florida Medical Center

Stephen E. Gitelman, MD
Professor of Clinical Pediatrics
KAK Distinguished Professor in Pediatric Diabetes and Clinical Research
University of California-San Francisco